PubRank

Hideto Tamura

Author PubWeight™ 56.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 2002 23.42
2 Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res 2005 4.94
3 B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Res 2003 3.96
4 B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003 3.47
5 Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis. J Clin Invest 2003 1.87
6 Disease progression mechanism in myelodysplastic syndromes: insight into the role of the microenvironment. Leuk Res 2011 1.44
7 Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: a multicenter validation study. Leuk Res 2012 1.42
8 Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes. Blood 2006 1.27
9 Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes. Leuk Res 2007 1.23
10 Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study. Haematologica 2012 1.18
11 Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study. Haematologica 2009 1.16
12 Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes. Blood 2010 1.07
13 Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood 2002 1.07
14 Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease. J Clin Invest 2002 1.07
15 Ribavirin downmodulates inducible costimulator on CD4+ T cells and their interleukin-10 secretion to assist in hepatitis C virus clearance. J Gastroenterol Hepatol 2012 0.89
16 Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes. Leuk Res 2008 0.89
17 Identification and hematopoietic potential of CD45- clonal cells with very immature phenotype (CD45-CD34-CD38-Lin-) in patients with myelodysplastic syndromes. Stem Cells 2005 0.88
18 [Evaluation of the enhanced International Prognostic Index (NCCN-IPI) for cases with diffuse large B-cell lymphoma]. Rinsho Ketsueki 2015 0.83
19 Induction of tumor-specific acquired immunity against already established tumors by selective stimulation of innate DEC-205(+) dendritic cells. Cancer Immunol Immunother 2010 0.83
20 Ribavirin modulates the conversion of human CD4(+)  CD25(-) T cell to CD4(+)  CD25(+)  FOXP3(+) T cell via suppressing interleukin-10-producing regulatory T cell. Immunology 2012 0.82
21 Selective expansion of perforin-positive CD8+ T cells by immature dendritic cells infected with live Bacillus Calmette-Guérin mycobacteria. J Leukoc Biol 2002 0.81
22 Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: a multicenter retrospective study. Leuk Res 2013 0.80
23 Association between phenotypic features of blasts and the blast percentage in bone marrow of patients with myelodysplastic syndromes. Leuk Res 2004 0.79
24 Functional B7.2 and B7-H2 molecules on myeloma cells are associated with a growth advantage. Clin Cancer Res 2009 0.78
25 Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes. Leuk Lymphoma 2012 0.77
26 Increased apoptosis of circulating T cells in myelodysplastic syndromes. Leuk Res 2007 0.77
27 Leucocyte-associated immunoglobulin-like receptor-1 is an inhibitory regulator of contact hypersensitivity. Immunology 2009 0.76
28 Recent advances and future challenges in cancer immunotherapy. Rinsho Ketsueki 2016 0.75
29 [Single vs double stem cell transplantation for the treatment of multiple myeloma]. Nihon Rinsho 2015 0.75
30 Simultaneous novel BCR-ABL gene mutation and increased expression of BCR-ABL mRNA caused clinical resistance to STI571 in double-Ph-positive acute biphenotypic leukemia. Int J Hematol 2003 0.75